EU Catches On: Drug Companies Abuse Patent System To Block Competition
from the well,-duh dept
I'm long overdue on some promised posts concerning the patent system and the harm it does for the healthcare field, but it's going to have to wait a little while longer. In the meantime, it's good to see that more people (including those in a position to do something about it) are noticing this as well. While we often feel that the EU goes overboard in declaring monopolies or anti-competitive behavior, it's finally realizing the one area where monopolies really do tend to be a problem: patents. The European Commission has released a report detailing how pharmaceutical companies regularly abuse the patent process for anti-competitive purposes, rather than to promote and ensure progress. It's unlikely that much will come of this now, but it's good to see people starting to recognize that the patent system can often be more of a problem than a solution.